Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-pot synthesis for 2-arylaminoacetamide compounds reduces hazardous waste and improves safety for scalable pharmaceutical intermediate manufacturing supply chains.
Novel palladium-copper catalytic method for phenanthrene intermediates ensures high purity and scalable production for global pharmaceutical supply chains efficiently.
Patent CN106928191B reveals improved Lansoprazole production with higher purity and yield. This process offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel patent CN110878104B details a safer two-step route for chiral 1,2-bis(2,5-diphenylphosphino)ethane, offering significant cost reduction and supply reliability for pharmaceutical manufacturers.
Patent CN104230853A details a robust synthesis route for pharmaceutical intermediates. This method offers significant supply chain reliability and cost optimization advantages.
Patent CN103880883A details a novel P2O5-mediated route for Tenofovir Dipivoxil, reducing impurities and enhancing supply chain reliability for API manufacturers.
Patent CN106957878B reveals a novel enzymatic route for 2-phenethyl alcohol using L-phenylalanine. Achieves high conversion without toxic byproducts, offering a reliable supply chain solution.
Patent CN112876427B reveals a greener Acesulfame K route eliminating SO3 and triethylamine, offering significant cost reduction and yield improvement for sweetener manufacturers.
Patent CN111072555A details a green HEH-catalyzed method for heterocyclic sulfones, offering cost reduction and supply chain reliability for pharma intermediates.
Patent CN114656494B reveals a novel chitosan copper catalyst for allyl borate synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110386885A enables metal-free visible light synthesis of β-carbonyl sulfones. Achieve cost reduction in fine chemical manufacturing with scalable, green protocols.
Patent CN103254075A reveals a novel synthesis for Flurbiprofen Axetil achieving >99% purity. Discover cost-effective manufacturing and reliable supply chain solutions.
Novel PPA/TFAA catalyzed route for Ramosetron eliminates resolution steps, offering high purity and cost-effective manufacturing for global supply chains.
Patent CN112028872A reveals metal-free synthesis of dibenzoselenophenes. High yield, broad scope, ideal for OLED materials. Cost-effective supply chain solution.
Patent CN111170958A details a green solid-acid catalyzed route for hydroxybenzomorph, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN115010563B reveals a green nickel-catalyzed halogen exchange method. This technology offers cost reduction in pharmaceutical intermediate manufacturing via mild visible light conditions.
Patent CN116693542A details silver-catalyzed spiro tetrahydroquinoline synthesis. Offers high purity, mild conditions, and supply chain advantages for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed synthesis offers high yield and enantioselectivity for antibacterial pharmaceutical intermediates, ensuring supply chain stability and cost efficiency.
Patent CN117756739B reveals Pd NHC catalysis for benzazepine lactones. Offers mild conditions and antibacterial applications for reliable pharmaceutical intermediates supply chains.
Patent CN114014865A details a Cu-catalyzed oxidative coupling for asymmetric trimeric indoles, offering high yields and simplified purification for electronic chemical manufacturing.